Oral 5-FU alternatives for the treatment of head and neck cancer

ONCOLOGY

Volumn 12, Issue 10 SUPPL. 7, 1998, Pages 35-38

  Yokes, Everett E ^a   Brockstein, Bruce E ^a   Humerickhouse, Rod ^a   Haraf, Daniel J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; 5 ETHYNYLURACIL; CAPECITABINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; ETOPOSIDE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; HYDROXYUREA; NAVELBINE; PACLITAXEL; SATRAPLATIN; TEGAFUR; UFT;

ADVANCED CANCER; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; DRUG RESPONSE; DYSPHAGIA; EARLY CANCER; FEEDING APPARATUS; HEAD AND NECK CANCER; HUMAN; HYPOALBUMINEMIA; INTRAVENOUS DRUG ADMINISTRATION; LIVER DYSFUNCTION; MALNUTRITION; ORAL DRUG ADMINISTRATION; RADIOSENSITIZATION; RECURRENT CANCER;

ADMINISTRATION, ORAL; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; ETOPOSIDE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; HYDROXYUREA; NEOPLASM RECURRENCE, LOCAL; TEGAFUR; URACIL;

EID: 0031730161     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Yokes EE, Weichselbaum RR, Lippman S, et al: Head and neck cancer. N Engl J Med 328:184-194, 1993.
2. Collins S, Stupp R, Douglierty M, et al: Head and Neck Cancer, in Abeloff, Armitage, Lichter, Niederhuber (eds): Clinical Oncology, pp 961-1022. New York, Churchill Livingstone, 1995.
3. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1991.
4. Lefebvre JL, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European organization for research and treatment of cancer phase III trial. J Natl Cancer Inst 88:890-899, 1996.
5. El-Sayed S, Nelson N: Adjuvant and adjuvantive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials. J Clin Oncol 14:838-847, 1996.
6. Brizel DM, Albers ME, Fisher SR, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338(25): 1798-1804, 1998.
7. Wendt TG, Grabenbauer GG, Rodel CM, et al: Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 16(4):1318-1324, 1998.
8. Al-Sarraf M, LeBlanc M, Shanker PG, et al: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 16(4):1310-1317, 1998.
9. Browman GP, Cripps C, Hodson I, et al: Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy and locally advanced head and neck cancer. J Clin Oncol 12:2648-2653, 1994.
10. Haffty BG, Son YH, Papac R, et al: Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale Mitomycin Randomized Trials. J Clin Oncol 15(1):268-276, 1997.
11. Jacobs C, Lyman G, Velez-Garcia E, et al: A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 10:257-263, 1992.
12. Yokes EE, Panje WR, Schilsky RL, et al: Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: A phase I-II study. J Clin Oncol 7:761-768, 1989.
13. Schrijvers D, Johnson J, Jiminez U, et al: Phase III trial of modulation of cisplatin/ fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. J Clin Oncol 16:1054-1059, 1998.
14. Forastiere AA, Metch B, Schuller DE, et al: Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 10:1245-1251, 1992.
15. Yokes EE, Haraf DJ, Mick R, et al: Intensified concomitant chemoradiotherpay with and without filgrastim for poor prognosis head and neck cancer. J Clin Oncol 12:2351-2359, 1994.
16. Haraf DJ, Weichselbaum RR, Yokes EE: Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: A potentially curable disease. Ann Oncol 7:913-918, 1996.
17. Yokes E, Haraf D, Weichselbaum R, et al: Fluorouracil, hydroxyurea and concomitant radiotherapy for stage II and III head and neck cancer. Fourth International Congress on AntiCancer Chemotherapy, Paris, p 67, 1993.
18. Yokes EE, Kies MK, Haraf DJ, et al: Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease. J Clin Oncol 13:876-883, 1995.
19. Kies MS, Haraf DJ, Athanasiadis I, et al: Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. J Clin Oncol 16(8):2715-2721, 1998.
20. Humerickhouse R, Dolan E, Brockstein B, et al: Phase I study of a novel DPD inhibitor GW776C85 and oral 5-FU with RT in recurrent or advanced head and neck cancer (abstract 1521). Proc Am Soc Clin Oncol 17:394a, 1998.
21. Tanaka J, Inuyama Y, Fujii M, et al: Clinical trials on UFT in the treatment of head and neck cancer. Auris Nasus Larynx 12:5261-5266, 1985.
22. Gonzalez-Baron M, Vicente J, Tomas M, et al: Phase II trial of cisplatin and tegafur (Ftorafur) as initial therapy in squamous-cell carcinoma of the head and neck. Am J Clin Oncol 13:312-314, 1990.
23. Feliu J, Gonzalez-Baron M, Zamara P, et al: Experience of Oncopaz cooperative group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck and breast. Oncology 54:30-37, 1997.
24. Gonzalez-Larriba JL, Carbonero IG, Valera JS, et al: Neoadjuvant therapy with cisplatin/ fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer. Oncology 11:90-97, 1997.
25. Takahashi H, Yao K, Sawaki S, et al: Investigation of UFT and radiation combination therapy of head and neck cancer - mainly in laryngeal cancer. Gan To Kagaku Ryoho 17:2037-2042, 1990.
26. Grunberg SM, Felman IE, Gala KV, et al: Phase II study of etoposide (VP-16) in the treatment of advanced head and neck cancer. Am J Clin Oncol 8:393-395, 1985.